Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study
Background: The aim of this study was to investigate the impact of proton pump inhibitor (PPI) therapy on complications and prognosis in cirrhosis patients with and without acute-on-chronic liver failure (ACLF).Materials and Methods: Cirrhosis patients with acute decompensation (AD) (n = 489) admitt...
Guardado en:
Autores principales: | Shanshan Sun, Wenyi Ye, Ruihong Zhao, Jianhua Hu, Xuan Zhang, Meifang Yang, Hong Zhao, Jifang Sheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d72ea231afe2426f884e47b02ef875c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Tomomi Kogiso, et al.
Publicado: (2021) -
Sequential Changes in the Mesenteric Lymph Node Microbiome and Immune Response during Cirrhosis Induction in Rats
por: Alba Santiago, et al.
Publicado: (2019) -
Prognostic impact of uric acid in patients with acute decompensated heart failure
por: Svetlana N. Nasonova, et al.
Publicado: (2021) -
Development and Validation of a Prediction Model for Acute Kidney Injury Among Patients With Acute Decompensated Heart Failure
por: Lei Wang, et al.
Publicado: (2021) -
Acute Decompensated Heart Failure and the Kidney: Physiological, Histological and Transcriptomic Responses to Development and Recovery
por: Miriam T. Rademaker, et al.
Publicado: (2021)